Design, Synthesis and Biological Evaluation of Potent Piperazine-Based BioA Inhibitors Targeting Biotin Biosynthesis in Mycobacterium tuberculosis
Journal of Medicinal Chemistry · 14.05.2026 · 69 (9) · 10315-10337
DOI: 10.1021/acs.jmedchem.5c03325 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 22.04.2026. Verfasst von Qiang Liu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, University of Minnesota, 308 Harvard Street SE, Minneapolis, Minnesota 55455, United States. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Drug Design, Biotin, Antitubercular Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: National Cancer Institute, National Institutes of Health.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicinal Chemistry, University of Minnesota, 308 Harvard Street SE, Minneapolis, Minnesota 55455, United States.
- Department of Microbiology and Immunology, Weill Cornell Medical College, 1300 York Avenue, New York, New York 10021, United States.
- Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey 07110, United States.
- Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, Omaha, Nebraska 68198, United States.
ORCID-Profile: Qiang Liu, Tsung-Yun Wong, Moyosore O Orimoloye, Yahani P Jayasinghe, Donald R Ronning, Véronique Dartois, Jansy P Sarathy, Dirk Schnappinger, Courtney C Aldrich
Förderung
- National Cancer Institute
- National Institutes of Health
Zitieren
APA
Liu, Q., Engelhart, C. A., Wallach, J. B., Ge, P., Wong, T. Y., Orimoloye, M. O., Rodriguez, S., Jayasinghe, Y. P., Ronning, D. R., Dartois, V., Sarathy, J. P., Schnappinger, D., Zimmerman, M. D., & Aldrich, C. C. (2026). Design, Synthesis and Biological Evaluation of Potent Piperazine-Based BioA Inhibitors Targeting Biotin Biosynthesis in Mycobacterium tuberculosis. Journal of Medicinal Chemistry, 69(9), 10315-10337. https://doi.org/10.1021/acs.jmedchem.5c03325
Vancouver
Liu Q, Engelhart CA, Wallach JB, Ge P, Wong TY, Orimoloye MO, et al. Design, Synthesis and Biological Evaluation of Potent Piperazine-Based BioA Inhibitors Targeting Biotin Biosynthesis in Mycobacterium tuberculosis. Journal of Medicinal Chemistry. 2026;69(9):10315-10337. doi:10.1021/acs.jmedchem.5c03325
BibTeX
@article{Liu2026,
author = {Liu, Qiang and Engelhart, Curtis A and Wallach, Joshua B and Ge, Peng and Wong, Tsung-Yun and Orimoloye, Moyosore O and Rodriguez, Suyapa and Jayasinghe, Yahani P and Ronning, Donald R and Dartois, Véronique and Sarathy, Jansy P and Schnappinger, Dirk and Zimmerman, Matthew D and Aldrich, Courtney C},
title = {Design, Synthesis and Biological Evaluation of Potent Piperazine-Based BioA Inhibitors Targeting Biotin Biosynthesis in Mycobacterium tuberculosis},
journal = {Journal of Medicinal Chemistry},
year = {2026},
volume = {69},
number = {9},
pages = {10315--10337},
doi = {10.1021/acs.jmedchem.5c03325}
}
EUVIMED